Skip to main content
eScholarship
Open Access Publications from the University of California

Prolonged survival in patients >= 60 years with first relapsed/refractory acute myeloid leukemia treated with vosaroxin plus cytarabine vs placebo plus cytarabine: Results from the phase 3 VALOR study

  • Author(s): Krug, U
  • Ravandi, F
  • Ritchie, EK
  • Sayar, H
  • Lancet, JE
  • Craig, MD
  • Vey, N
  • Strickland, SA
  • Schiller, GJ
  • Jabbour, E
  • Erba, HP
  • Pigneux, A
  • Horst, H-A
  • Recher, C
  • Klimek, VM
  • Cortes, J
  • Roboz, GJ
  • Craig, AR
  • Fox, JA
  • Ward, R
  • Smith, JA
  • Acton, G
  • Mehta, C
  • Kantarjian, HM
  • Stuart, RK
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822512/
No data is associated with this publication.
Item not freely available? Link broken?
Report a problem accessing this item